Klebsiella pneumoniae, a bacterium found in the gut, may reach the brain and affect Alzheimer's disease progression, research ...
Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...
Braisted said wandering is a risk for every person living with Alzheimer's or other dementias. "So, it's really important to ...
As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...
Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in ...
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...
U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...
Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...
The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.
An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback